Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abscess, intracerebral
acute disseminated encephalomyelitis
adverse drug reaction
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, preclinical
amyloid beta protein
amyloid imaging
amyloid plaques
angiitis, isolated of CNS
anti MAG antibodies
antibodies to myelin basic protein
antimyelin antibodies
asymptomatic
ataxia
autoantibodies
autoimmune disease
axonal degeneration
axonal transection
B cell lymphocytes
Barkhof MR criteria for MS
BCG vaccination
BENEFIT study
biologic markers
brain atrophy
brain biopsy
brain volume
brainstem
brainstem, infarction of
brainstem, lesion of
carcinoma
carcinoma of breast
carotid artery occlusion, intracranial
CAT scan
CAT scan, abnormal
CAT scan, cerebrovascular disease
CAT scan, dense artery sign
CAT scan, early changes in CVA
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, mass effect on
CAT scan, ring sign
central nervous system, infection of
central vein sign
cerebellar infarction
cerebellar lesion
cerebral arteries
cerebral infarction
cerebral infarction, hemorrhagic
cerebral ischemia
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrospinal fluid, oligoclonal IgG in
cerebrospinal fluid, protein of
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, arterial occlusion, location
cerebrovascular accident, prognosis in
cerebrovascular accident, recurrent
cerebrovascular accident, severity
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, volume
cerebrovascular accident, work up for
cerebrovascular accident, young adult
children
Clinical Pathologic Conference(C.P.C.)
cognition
comorbidities
complications
controversies in neurology
cop 1
corneal dystrophy
corpus callosum
corpus callosum, lesion of
cyclophosphamide
degenerative diseases of CNS
dementia
dementia, diagnostic evaluation of
dementia, early detection
dementia, presenile
dementia, rapidly progressive
dementia, screening for
demyelinating disease
diabetes insipidus
diagnostic criteria
differential diagnosis
disability rating scale, neurological
disability, neurological
disease modifying agents
efficacy
encephalitis
encephalitis, viral
encephalomyelitis, postinfectious
encephalopathy, Hashimoto's
encephalopathy, metabolic
endovascular therapy
enzyme, defect
Epstein-Barr virus
evoked potentials
Fabry's disease
falling
fever
fibrinolytic agents
fibrinolytic agents, complications
fingolimod
florbetapir
flu-like illness
fourth ventricle, shift of
fumarate
gadolinium
gait disorder
gammaglobulin therapy, intravenous
genetic neurologic disorders
head injury
hearing loss
hearing loss, sudden, unilateral
hemiparesis
heralding manifestation
herpes simplex encephalitis
herpes virus
herpes virus infection
hippocampal atrophy
hippocampus
hydrocephalus
hydrocephalus, exvacuo
hypertension
immunomodulation
immunosuppressive agents
immunotherapy
infection
interferon
interferon beta 1-a
interferon beta 1-b
internal carotid artery
intracerebral hemorrhage
intravenous
iron, brain
ischemic penumbra
Jakob-Creutzfeldt disease
Kappa light chain biomarkers
laquinimod
L-dopa
leukoencephalopathy
leukopenia
liver function enzymes
lobar atrophy
Marburg's disease
McDonald criteria for MS
medulla oblongata, infarction of
memory, impairment of
mild cognitive impairment
misdiagnosis
mitoxantrone
monoclonal antibodies
MRI
MRI lesion location
MRI, abnormal
MRI, ADC maps
MRI, angiography
MRI, cerebrovascular disease
MRI, contrast enhanced
MRI, demyelinating disease
MRI, diffusion weighted
MRI, early changes in CVA
MRI, false negative
MRI, fast
MRI, field strength
MRI, field strength, high
MRI, functional
MRI, gradient-echo
MRI, incidental finding
MRI, lesion burden
MRI, mass effect on
MRI, negative
MRI, optic nerve
MRI, paramagnetic effect
MRI, perfusion
MRI, ring sign
MRI, serial
MRI, spinal cord
MRI, susceptibility weighted
MRI, volumetry
MRS
multiple sclerosis
multiple sclerosis, acute
multiple sclerosis, asymptomatic
multiple sclerosis, children
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, conversion to clinically definite
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, early onset
multiple sclerosis, etiology of
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, MRI conversion
multiple sclerosis, MRI criteria
multiple sclerosis, pathogenesis
multiple sclerosis, preclinical
multiple sclerosis, presenting manifestations
multiple sclerosis, prognosis
multiple sclerosis, prophylaxsis
multiple sclerosis, radiologically isolated syndrome
multiple sclerosis, relapsing
multiple sclerosis, risk factors for
multiple sclerosis, secondary progressive
multiple sclerosis, spinal form
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
N-acetyl-L-aspartic acid
natalizumab
neoplasm, intracranial
neoplasm, primary intracerebral
neoplasm, primary intracranial
neoplasm, primary of CNS
neoplasm, primary of CNS-children
neurologic disease, diagnoses of
neurologic signs
neurologic symptoms
neuropathology
neuroprotective agents
neurosyphilis
NIH stroke scale
nystagmus
ocrelizumab
old age, neurology of
optic nerve, lesion of
optic neuritis
optic neuritis, bilateral
optic neuritis, children
optic neuritis, etiology of
optic neuritis, recurrent
optic neuritis, treatment of
optical coherence tomography
paramagnetic rim lesion, MR
Parkinson disease
Parkinson disease, late onset
Parkinson disease, treatment of
Parkinson disease, young onset
periventricular leukomalacia
Pittsburgh Compound B
placebo
pons, infarction of
posterior cerebral artery territory infarction
posterior fossa
posterior fossa, lesion of
practice guidelines
preclinical
pregnancy, neurologic complications in
prevention of neurologic disorders
prion disease
prognosis
progressive neurologic disorder
protein 14-3-3, cerebrospinal fluid
pseudotumor
rapidly progressing neurologic illness
remote effect of cancer on the nervous system
revascularization, surgical
review article
risk factors
safety
sarcoidosis, CNS
screening
seizure
seizure, children
sensorineural hearing loss
serologic testing
single photon emission computed tomography
slurred speech
somnambulism
spinal cord
spinal cord, enlargement
spinal cord, intramedullary cyst of
spinal cord, lesion of
spinal cord, neoplasm
spinal cord, neoplasm, infants and children
steroid
steroid therapy, CNS treatment and complications with
stroke disability scale
symmetric brain lesions
symptomatic
syphilis, diagnosis and treatment
syphilis, neurologic complications with
syringomyelia
T lesion of MCA-ICA
temporal lobe, atrophy
thyroiditis
tinnitus
tissue plasminogen activator, intravenous
toxic encephalopathy
transient ischemic attack
treatment of neurologic disorder
uremia
urinary incontinence
urinary retention
ventricular enlargement
vertebral-basilar insufficiency
vertigo
vertigo, episodic
viral infection
viral infection, CNS
viral infection, reactivation
visual evoked response
West Nile fever
white matter disease
white matter disease, periventricular
Showing articles 1400 to 1450 of 4413 << Previous Next >>

Investigation of Failed Low Back Surgery
Editorial, Lancet 1:939-9401989., , 1989

Neck Sprains after Car Accidents, A Common Cause of Long Term Disability
BMJ 298:973-974, Porter,K.M., 1989

Multiple Sclerosis Simulating Brain Tumor on Computed Tomography
J Comput Assist Tomogr 13:674-678, Otsuka,S.I.,et al, 1989

Cerebrospinal Fluid Immunoglogulins & MS, Correspondence MRI & Visually Evoked Potential Changes
Arch Neurol 46:367-371, Miller,F.A.J.,et al, 1989

The Lesion of Multiple Sclerosis:Imaging of Acute and Chronic Stages
Neurol 39:959-963, Koopmans,R.A.,et al, 1989

Chronic Progressive Multiple Sclerosis:Serial Magnetic Resonance Brain Imaging Over Six Months
Ann Neurol 26:248-256, Koopmans,R.A.,et al, 1989

Non Ischaemic Causes of Lacunar Syndromes:Prevalence and Clinical Findings
JNNP 52:1188-1190, Anzalone,N.&Landi,G., 1989

Neurologic Status and Intracranial Hemorrhage in Very-Low-Birth Weight Preterm Infants
Am J Dis Child 143:1186-1190, Ford,L.M.,et al, 1989

Divisional Oculomotor Nerve Paresis Caused by Intrinsic Brainstem Disease
Ann Neurol 26:714-718, Ksiazek,S.M.,et al, 1989

The Remote Effects of Cancer on the Nervous System
in Neurol Manif of Systemic Dis, W. B. Saunders, Co, Phila, Neurologic Clinics 7:579-603, Dropcho,E.J., 1989

Clinicopath Conf
Primary (Granulomatous) Angiitis of Central Nervous System, Case Record 8-1989, NEJM 320:514-5249., , 1989

The Prevalence of Primary Sjogren's Syndrome in a Multiple Sclerosis Population
Ann Neurol 25:95-98, Noseworthy,J.H.,et al, 1989

Multiple Sclerosis-Like Illness Occurring with Human Immunodeficiency Virus Infection
Neurol 39:324-329, Berger,J.R.,et al, 1989

Chronic Myelopathies Associated with HTLV-I, A Clinical, Serologic, and Immunovirologic Study of 10 Patients in France
Arch Neurol 46:255-260, Gout,O.,et al, 1989

Clinical Significance of Cerebrospinal Fluid Tests for Neurosyphilis
Ann Neurol 25:50-55, Davis,L.E.&Schmitt,J.W., 1989

Significance of the Argyll Robertson Pupil in Clinical Medicine
Am J Med 86:199-202, Dacso,C.C.&Bortz,D.L., 1989

Hemorrhagic Shock and Encephalopathy:Clinical, Pathologic, and Biochemical Features
J Pediatr 114:194-203, Levin,M.,et al, 1989

Brain-Stem Auditory Evoked Potential Abnormalities with Unilateral Brain-Stem Lesions Demonstrated by MRI
Arch Neurol 46:295-299, Markand,O.N.,et al, 1989

Serial Magnetic Resonance Scanning in Multiple Sclerosis:A Second Prospective Study in Relapsing Patients
Ann Neurol 25:43-49, Willoughby,E.W.,et al, 1989

Benign Versus Chronic Progressive Multiple Sclerosis:Magnetic Resonance Imaging Features
Ann Neurol 25:74-81, Koopmans,R.A.,et al, 1989

Short-Term Outcomes of Skull Fracture:A Population-Based Study of Survival and Neurologic Complications
Neurol 39:96-102, Wiederholt,W.C.,et al, 1989

Concurrence of Multiple Sclerosis and Inflammatory Bowel Disease
NEJM 321:762-763, Sadovnick,A.D.,et al, 1989

Relative Diagnostic Value of Cerebrospinal Fluid Kappa Chains in MS:Comparison with Other Immunoglobulin Tests
Neurol 39:964-968, Rudnick,R.A.,et al, 1989

Patterns of Neurologic Involvement in Multiple Sclerosis
Neurol 39:1235-1238, Kurtzke,J.F., 1989

Magnetic Resonance Imaging of Spinal Cord Lesions in Multiple Sclerosis
JNNP 52:459-466, Honig,L.S.&Sheremata,W.A., 1989

A Referendum on Clinical Trial Research in Multiple Sclerosis:Opinion of Jekyll Island Workshop
Neurol 39:977-981, Noseworthy,J.H.,et al, 1989

Isolation of Herpes Simplex Virus Type 1 During First Attack of Multiple Sclerosis
Ann Neurol 26:283-285, Bergstrom,T.,et al, 1989

Diagnosis of Multiple Sclerosis, Remains Essentially Clinical Though Silent Lesions Can Now be Identified
BMJ 299:635-637, McDonald,W.I., 1989

Amantadine Treatment of Fatigue Associated with Multiple Sclerosis
Arch Neurol 46:676-680, Cohen,R.A.&Fisher,M., 1989

Relative Efficacy of Intravenous Methylprednisolone and ACTH in the Treatment of Acute Relapse in MS
Neurol 39:969-971, Thompson,A.J.,et al, 1989

Interrater Reliability of the NIH Stroke Scale
Arch Neurol 46:660-662, Goldstein,L.B.,et al, 1989

Double-Blind Study of True vs. Sham Plasma Exchange in Patients Treated with Immunosuppression for Acute Attacks of MS
Neurol 39:1143-1149, Weiner,H.L.,et al, 1989

Randomised Double Blind Controlled Trial of Cyclosporin in Multiple Sclerosis
JNNP 52:559-565, Rudge,P.,et al, 1989

A Placebo-Controlled, Randomized, Clinical Trial of Azathioprine with & without Methylpred in MS
Neurol 39:1018-1026, Ellison,G.W.,et al, 1989

Immunological Treatment for Multiple Sclerosis
Editorial, Lancet 1:699-7011989., , 1989

Treatment of Cerebellar Tremors with Carbamazepine:A Controlled Trial with Long-Term Follow-Up
Neurol 39:1113-1115, Sechi,G.P.,et al, 1989

An Epidemiologic Study of Headache Among Adolescents and Young Adults
JAMA 261:2211-2216, Linet,M.S.,et al, 1989

Tuberculous Meningitis in Children:Treatment with Isoniazid and Rifampicin for Twelve Months
J Pediatr 114:875-879, Visudhiphan,P.&Chiemchanya,S., 1989

Central Nervous System Manifestations of Lyme Disease
Arch Neurol 46:790-795, Pachner,A.R.,et al, 1989

Lyme Neuroborreliosis:Central Nervous System Manifestations
Neurol 39:753-759, Halperin,J.J.,et al, 1989

Brain Damage by Neonatal Hypoglycaemia
Editorial, Lancet 1:882-8831989., , 1989

Intrathecal Baclofen for Severe Spinal Spasticity
NEJM 320:1517-1521, 1553-15551989., Penn,R.D.,et al, 1989

Intrathecal Baclofen for Long-Term Treatment of Spasticity:A Multi-Centre Study
JNNP 52:933-939, Ochs,G.,et al, 1989

Magnetism, A New Method for Stimulation of Nerve and Brain
JAMA 262:538-541, Hallett,M.&Cohen,L.G., 1989

Accuracy of Self-Reported Disability in Patients with Parkinsonism
Arch Neurol 46:955-959, Brown,R.G.,et al, 1989

Demyelinating Diseases
In Rowlands Merritt's Textbk of Neurology, Lea & Febiger, Phila, 8th Ed, p. 749, Sibley,W.A.,et al, 1989

Clinical Presentations of Vascular Malformations of the Brain Stem:Comparison of Angiographically Positive and Negative Types
JNNP 52:167-175, Abe,M.,et al, 1989

Sneddon Syndrome:CT, Arteriography, and MR Imaging
J Comput Assist Tomogr 13:119-122, Blom,R.J., 1989

Severely Threatening Events and Marked Life Difficulties Preceding Onset or Exacerbation of MS
JNNP 52:8-13, Grant,I.,et al, 1989

The Disability Status Scale for Multiple Sclerosis:Apologia Pro DSS Sau
Neurol 39:291-302, Kurtzke,J.F., 1989



Showing articles 1400 to 1450 of 4413 << Previous Next >>